aldosterone has been researched along with Apoplexy in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 10 (23.26) | 29.6817 |
| 2010's | 23 (53.49) | 24.3611 |
| 2020's | 9 (20.93) | 2.80 |
| Authors | Studies |
|---|---|
| Parksook, WW | 1 |
| Williams, GH | 1 |
| Nguyen, V | 1 |
| Tu, TM | 1 |
| Mamauag, MJB | 1 |
| Lai, J | 1 |
| Saffari, SE | 1 |
| Aw, TC | 1 |
| Ong, L | 1 |
| Foo, RSY | 1 |
| Chai, SC | 1 |
| Fones, S | 1 |
| Zhang, M | 2 |
| Puar, TH | 1 |
| Sarfo, FS | 1 |
| Ovbiagele, B | 1 |
| Meng, Y | 2 |
| Chen, K | 1 |
| Xie, A | 1 |
| Liu, Y | 1 |
| Huang, J | 1 |
| De Silva, TM | 1 |
| Faraci, FM | 1 |
| Bobenko, AI | 1 |
| Heller, S | 1 |
| Schmitt, N | 1 |
| Cherdtrakulkiat, R | 1 |
| Lawung, R | 1 |
| Nabu, S | 1 |
| Tantimavanich, S | 1 |
| Sinthupoom, N | 1 |
| Prachayasittikul, S | 1 |
| Prachayasittikul, V | 1 |
| Zhang, B | 1 |
| Wu, C | 1 |
| Zhang, Z | 3 |
| Yan, K | 1 |
| Li, C | 2 |
| Li, Y | 4 |
| Li, L | 3 |
| Zheng, C | 1 |
| Xiao, Y | 1 |
| He, D | 1 |
| Zhao, F | 1 |
| Su, JF | 1 |
| Lun, SM | 1 |
| Hou, YJ | 1 |
| Duan, LJ | 1 |
| Wang, NC | 1 |
| Shen, FF | 1 |
| Zhang, YW | 1 |
| Gao, ZW | 1 |
| Li, J | 5 |
| Du, XJ | 1 |
| Zhou, FY | 1 |
| Yin, Z | 1 |
| Zhu, J | 2 |
| Yan, D | 1 |
| Lou, H | 1 |
| Yu, H | 1 |
| Feng, C | 1 |
| Wang, Z | 2 |
| Wang, Y | 4 |
| Hu, X | 1 |
| Li, Z | 2 |
| Shen, Y | 1 |
| Hu, D | 1 |
| Chen, H | 2 |
| Wu, X | 1 |
| Duan, Y | 1 |
| Zhi, D | 1 |
| Zou, M | 2 |
| Zhao, Z | 1 |
| Zhang, X | 2 |
| Yang, X | 2 |
| Zhang, J | 2 |
| Wang, H | 1 |
| Popović, KJ | 1 |
| Popović, DJ | 1 |
| Miljković, D | 1 |
| Lalošević, D | 1 |
| Čapo, I | 1 |
| Popović, JK | 1 |
| Liu, M | 1 |
| Song, H | 2 |
| Xing, Z | 1 |
| Lu, G | 1 |
| Chen, D | 1 |
| Valentini, AM | 1 |
| Di Pinto, F | 1 |
| Coletta, S | 1 |
| Guerra, V | 1 |
| Armentano, R | 1 |
| Caruso, ML | 1 |
| Gong, J | 1 |
| Wang, N | 2 |
| Bian, L | 1 |
| Wang, M | 1 |
| Ye, M | 1 |
| Wen, N | 1 |
| Fu, M | 1 |
| Fan, W | 1 |
| Dong, G | 1 |
| Lin, XH | 1 |
| Liu, HH | 1 |
| Gao, DM | 1 |
| Cui, JF | 1 |
| Ren, ZG | 1 |
| Chen, RX | 1 |
| Önal, B | 1 |
| Özen, D | 1 |
| Demir, B | 1 |
| Akkan, AG | 1 |
| Özyazgan, S | 1 |
| Payette, G | 1 |
| Geoffroy, V | 1 |
| Martineau, C | 1 |
| Villemur, R | 1 |
| Jameel, T | 1 |
| Baig, M | 1 |
| Gazzaz, ZJ | 1 |
| Tashkandi, JM | 1 |
| Al Alhareth, NS | 1 |
| Khan, SA | 1 |
| Butt, NS | 1 |
| Wang, J | 2 |
| Geng, Y | 1 |
| Zhang, Y | 3 |
| Wang, X | 2 |
| Liu, J | 2 |
| Basit, A | 1 |
| Miao, T | 1 |
| Liu, W | 1 |
| Jiang, W | 1 |
| Yu, ZY | 1 |
| Wu, L | 2 |
| Qu, B | 1 |
| Sun, JX | 1 |
| Cai, AL | 1 |
| Xie, LM | 1 |
| Groeneveld, J | 1 |
| Ho, SL | 1 |
| Mackensen, A | 1 |
| Mohtadi, M | 1 |
| Laepple, T | 1 |
| Genovesi, S | 1 |
| Nava, E | 1 |
| Bartolucci, C | 1 |
| Severi, S | 1 |
| Vincenti, A | 1 |
| Contaldo, G | 1 |
| Bigatti, G | 1 |
| Ciurlino, D | 1 |
| Bertoli, SV | 1 |
| Slovak, JE | 1 |
| Hwang, JK | 1 |
| Rivera, SM | 1 |
| Villarino, NF | 1 |
| Li, S | 1 |
| Cao, G | 1 |
| Ling, M | 1 |
| Ji, J | 1 |
| Zhao, D | 1 |
| Sha, Y | 1 |
| Gao, X | 1 |
| Liang, C | 2 |
| Guo, Q | 1 |
| Zhou, C | 1 |
| Ma, Z | 1 |
| Xu, J | 1 |
| Wang, C | 1 |
| Zhao, W | 1 |
| Xia, X | 1 |
| Jiang, Y | 1 |
| Peng, J | 1 |
| Jia, Z | 1 |
| Li, F | 1 |
| Chen, X | 2 |
| Mo, J | 1 |
| Zhang, S | 3 |
| Li, X | 1 |
| Huang, T | 1 |
| Zhu, Q | 1 |
| Wang, S | 1 |
| Ge, RS | 1 |
| Fortunato, G | 1 |
| Lin, J | 2 |
| Agarwal, PK | 1 |
| Kohen, A | 1 |
| Singh, P | 1 |
| Cheatum, CM | 1 |
| Zhu, D | 1 |
| Hayman, A | 1 |
| Kebede, B | 1 |
| Stewart, I | 1 |
| Chen, G | 1 |
| Frew, R | 1 |
| Guo, X | 1 |
| Gong, Q | 1 |
| Borowiec, J | 1 |
| Han, S | 1 |
| Willis, M | 1 |
| Kreouzis, T | 1 |
| Yu, K | 1 |
| Chirvony, VS | 1 |
| Sekerbayev, KS | 1 |
| Pérez-Del-Rey, D | 1 |
| Martínez-Pastor, JP | 1 |
| Palazon, F | 1 |
| Boix, PP | 1 |
| Taurbayev, TI | 1 |
| Sessolo, M | 1 |
| Bolink, HJ | 1 |
| Lu, M | 1 |
| Lan, Y | 1 |
| Xiao, J | 1 |
| Song, M | 1 |
| Chen, C | 1 |
| Huang, Q | 1 |
| Cao, Y | 1 |
| Ho, CT | 1 |
| Qi, B | 1 |
| Wang, Q | 1 |
| Zhang, W | 1 |
| Fang, L | 1 |
| Xie, CL | 1 |
| Chen, R | 1 |
| Yang, S | 2 |
| Xia, JM | 1 |
| Zhang, GY | 1 |
| Chen, CH | 1 |
| Yang, XW | 1 |
| Domenech-Ximenos, B | 1 |
| Garza, MS | 1 |
| Prat-González, S | 1 |
| Sepúlveda-Martínez, Á | 1 |
| Crispi, F | 1 |
| Perea, RJ | 1 |
| Garcia-Alvarez, A | 1 |
| Sitges, M | 1 |
| Kalumpha, M | 1 |
| Guyo, U | 1 |
| Zinyama, NP | 1 |
| Vakira, FM | 1 |
| Nyamunda, BC | 1 |
| Varga, M | 1 |
| Drácz, L | 1 |
| Kolbenheyer, E | 1 |
| Varga, F | 1 |
| Patai, ÁV | 1 |
| Solymosi, N | 1 |
| Patai, Á | 1 |
| Kiss, J | 1 |
| Gaál, V | 1 |
| Nyul, Z | 1 |
| Mosdósi, B | 1 |
| Valdez, M | 1 |
| Moosavi, L | 1 |
| Heidari, A | 1 |
| Novakovic-Agopian, T | 1 |
| Kornblith, E | 1 |
| Abrams, G | 1 |
| McQuaid, JR | 1 |
| Posecion, L | 1 |
| Burciaga, J | 1 |
| D'Esposito, M | 1 |
| Chen, AJW | 1 |
| Samy El Gendy, NM | 1 |
| Wesolowska, P | 1 |
| Georg, D | 1 |
| Lechner, W | 1 |
| Kazantsev, P | 1 |
| Bokulic, T | 1 |
| Tedgren, AC | 1 |
| Adolfsson, E | 1 |
| Campos, AM | 1 |
| Alves, VGL | 1 |
| Suming, L | 1 |
| Hao, W | 1 |
| Ekendahl, D | 1 |
| Koniarova, I | 1 |
| Bulski, W | 1 |
| Chelminski, K | 1 |
| Samper, JLA | 1 |
| Vinatha, SP | 1 |
| Rakshit, S | 1 |
| Siri, S | 1 |
| Tomsejm, M | 1 |
| Tenhunen, M | 1 |
| Povall, J | 1 |
| Kry, SF | 1 |
| Followill, DS | 1 |
| Thwaites, DI | 1 |
| Izewska, J | 1 |
| Kang, JH | 1 |
| Yoon, Y | 1 |
| Song, J | 1 |
| Van de Winckel, A | 1 |
| Gauthier, L | 1 |
| Chao, CT | 1 |
| Lee, YH | 1 |
| Li, CM | 1 |
| Han, DS | 1 |
| Huang, JW | 1 |
| Huang, KC | 1 |
| Ni, L | 1 |
| Güttinger, R | 1 |
| Triana, CA | 1 |
| Spingler, B | 1 |
| Baldridge, KK | 1 |
| Patzke, GR | 1 |
| Shen, X | 1 |
| Wang, B | 1 |
| Xie, S | 1 |
| Deng, W | 1 |
| Wu, D | 1 |
| Zhang, Q | 1 |
| Voskamp, BJ | 1 |
| Peelen, MJCS | 1 |
| Ravelli, ACJ | 1 |
| van der Lee, R | 1 |
| Mol, BWJ | 1 |
| Pajkrt, E | 1 |
| Ganzevoort, W | 1 |
| Kazemier, BM | 1 |
| Tibrewala, R | 1 |
| Bahroos, E | 1 |
| Mehrabian, H | 1 |
| Foreman, SC | 1 |
| Link, TM | 1 |
| Pedoia, V | 1 |
| Majumdar, S | 1 |
| Jablonski, CL | 1 |
| Leonard, C | 1 |
| Salo, P | 1 |
| Krawetz, RJ | 1 |
| Yoon, N | 1 |
| Hong, SN | 1 |
| Cho, JG | 1 |
| Jeong, HK | 1 |
| Lee, KH | 1 |
| Park, HW | 1 |
| Barman, S | 1 |
| Konai, MM | 1 |
| Samaddar, S | 1 |
| Haldar, J | 1 |
| Mohamed, HSH | 1 |
| Li, CF | 1 |
| Hu, ZY | 1 |
| Deng, Z | 1 |
| Chen, LH | 1 |
| Su, BL | 1 |
| Chu, K | 1 |
| Liu, YP | 1 |
| Li, YB | 1 |
| Zhang, H | 1 |
| Xu, C | 1 |
| Zou, Z | 1 |
| Wu, Z | 1 |
| Xia, Y | 1 |
| Zhao, P | 1 |
| Wang, HT | 1 |
| de Biase, S | 1 |
| Pellitteri, G | 1 |
| Gigli, GL | 1 |
| Valente, M | 1 |
| Tang, Z | 1 |
| He, W | 1 |
| Ma, L | 1 |
| Song, Y | 1 |
| Mei, M | 1 |
| Luo, T | 1 |
| Du, Z | 1 |
| Hu, J | 1 |
| Cheng, Q | 1 |
| Li, Q | 1 |
| Wang, L | 1 |
| Liu, D | 1 |
| Yuan, K | 1 |
| Zhu, G | 1 |
| Qi, X | 1 |
| Reisin, RC | 1 |
| Rozenfeld, P | 1 |
| Bonardo, P | 1 |
| Ling, QS | 1 |
| Zhang, SL | 1 |
| Tian, JS | 1 |
| Cheng, MH | 1 |
| Liu, AJ | 1 |
| Fu, FH | 1 |
| Liu, JG | 1 |
| Miao, CY | 1 |
| Joseph, JJ | 1 |
| Echouffo-Tcheugui, JB | 1 |
| Kalyani, RR | 1 |
| Yeh, HC | 1 |
| Bertoni, AG | 1 |
| Effoe, VS | 1 |
| Casanova, R | 1 |
| Sims, M | 1 |
| Wu, WC | 1 |
| Wand, GS | 1 |
| Correa, A | 2 |
| Golden, SH | 1 |
| Williams, SA | 1 |
| Murthy, AC | 1 |
| DeLisle, RK | 1 |
| Hyde, C | 1 |
| Malarstig, A | 1 |
| Ostroff, R | 1 |
| Weiss, SJ | 1 |
| Segal, MR | 1 |
| Ganz, P | 1 |
| Hillaert, MA | 2 |
| den Ruijter, HM | 1 |
| Hoefer, IE | 1 |
| Lentjes, EG | 1 |
| de Borst, GJ | 1 |
| de Vries, JPM | 1 |
| Doevendans, PA | 2 |
| Pasterkamp, G | 1 |
| Timmers, L | 1 |
| Cannone, V | 1 |
| Buglioni, A | 1 |
| Sangaralingham, SJ | 1 |
| Scott, C | 1 |
| Bailey, KR | 1 |
| Rodeheffer, R | 1 |
| Redfield, MM | 1 |
| Sarzani, R | 1 |
| Burnett, JC | 1 |
| Chen, L | 1 |
| Zhang, P | 1 |
| Shen, L | 1 |
| Huang, S | 1 |
| Zhang, C | 1 |
| Deng, B | 1 |
| Lambers Heerspink, HJ | 1 |
| He, DH | 1 |
| Zhang, LM | 1 |
| Lin, LM | 1 |
| Ning, RB | 1 |
| Wang, HJ | 1 |
| Xu, CS | 1 |
| Lin, JX | 1 |
| Sampson, AK | 1 |
| Mohammed, D | 1 |
| Beattie, W | 1 |
| Graham, D | 1 |
| Kenyon, CJ | 1 |
| Al-Dujaili, EA | 1 |
| Guryev, V | 1 |
| Mcbride, MW | 1 |
| Dominiczak, AF | 1 |
| Back, C | 1 |
| Thiesen, KL | 1 |
| Skovgaard, K | 1 |
| Edvinsson, L | 1 |
| Jensen, LT | 1 |
| Larsen, VA | 1 |
| Iversen, HK | 1 |
| Murakami, N | 1 |
| Yoshida, N | 1 |
| Hamano, K | 1 |
| Suzuki, H | 1 |
| Miyakawa, M | 1 |
| Takeshita, A | 1 |
| Takeuchi, Y | 1 |
| Wang, W | 1 |
| Shen, G | 1 |
| Shahar, E | 1 |
| Bidulescu, A | 1 |
| Kimberly, WT | 1 |
| Sheth, KN | 1 |
| Campbell, BW | 1 |
| Horbal, S | 1 |
| Griswold, ME | 1 |
| Miyaji, Y | 1 |
| Kawabata, Y | 1 |
| Joki, H | 1 |
| Seki, S | 1 |
| Mori, K | 1 |
| Kamide, T | 1 |
| Tamase, A | 1 |
| Shima, H | 1 |
| Nomura, M | 1 |
| Kitamura, Y | 1 |
| Nakaguchi, H | 1 |
| Minami, T | 1 |
| Tsunoda, T | 1 |
| Sasaki, M | 1 |
| Yamada, M | 2 |
| Tanaka, F | 1 |
| Jones, ES | 1 |
| Spence, JD | 2 |
| Mcintyre, AD | 1 |
| Nondi, J | 1 |
| Gogo, K | 1 |
| Akintunde, A | 1 |
| Hackam, DG | 1 |
| Rayner, BL | 1 |
| Pitts, R | 1 |
| Gunzburger, E | 1 |
| Ballantyne, CM | 1 |
| Barter, PJ | 1 |
| Kallend, D | 1 |
| Leiter, LA | 1 |
| Leitersdorf, E | 1 |
| Nicholls, SJ | 1 |
| Shah, PK | 1 |
| Tardif, JC | 1 |
| Olsson, AG | 1 |
| McMurray, JJ | 1 |
| Kittelson, J | 1 |
| Schwartz, GG | 1 |
| Mulatero, P | 1 |
| Caserta, M | 1 |
| Bertello, C | 1 |
| Schiavone, D | 1 |
| Verhovez, A | 1 |
| Giraudo, G | 1 |
| Morello, F | 1 |
| Veglio, F | 1 |
| Vyssoulis, GP | 1 |
| Karpanou, EA | 1 |
| Tzamou, VE | 1 |
| Kyvelou, SM | 1 |
| Michaelidis, AP | 1 |
| Gialernios, TP | 1 |
| Cokkinos, DV | 1 |
| Stefanadis, CI | 1 |
| Nakajima, Y | 1 |
| Taguchi, R | 1 |
| Satoh, T | 1 |
| Hashimoto, K | 1 |
| Ozawa, A | 1 |
| Shibusawa, N | 1 |
| Okada, S | 1 |
| Monden, T | 1 |
| Mori, M | 1 |
| Mangoni, AA | 1 |
| Knights, KM | 1 |
| Ivanes, F | 1 |
| Susen, S | 1 |
| Mouquet, F | 1 |
| Pigny, P | 1 |
| Cuilleret, F | 1 |
| Sautière, K | 1 |
| Collet, JP | 1 |
| Beygui, F | 1 |
| Hennache, B | 1 |
| Ennezat, PV | 1 |
| Juthier, F | 1 |
| Richard, F | 1 |
| Dallongeville, J | 1 |
| Jude, B | 1 |
| Bertrand, M | 1 |
| Montalescot, G | 1 |
| Van Belle, E | 1 |
| Nakagaki, T | 1 |
| Hirooka, Y | 1 |
| Matsukawa, R | 1 |
| Nishihara, M | 1 |
| Nakano, M | 1 |
| Ito, K | 1 |
| Hoka, S | 1 |
| Sunagawa, K | 1 |
| Satoh, M | 1 |
| Kikuya, M | 1 |
| Ohkubo, T | 1 |
| Mori, T | 1 |
| Metoki, H | 1 |
| Hara, A | 1 |
| Utsugi, MT | 1 |
| Hashimoto, T | 1 |
| Hirose, T | 1 |
| Obara, T | 1 |
| Inoue, R | 1 |
| Asayama, K | 1 |
| Kanno, A | 1 |
| Totsune, K | 1 |
| Hoshi, H | 1 |
| Satoh, H | 1 |
| Imai, Y | 1 |
| Smith, JH | 1 |
| Lindor, NM | 1 |
| Rabinstein, AA | 1 |
| Kisaka, T | 1 |
| Ozono, R | 1 |
| Ishida, T | 1 |
| Higashi, Y | 1 |
| Oshima, T | 1 |
| Kihara, Y | 1 |
| Di Legge, S | 1 |
| Tamayo, A | 1 |
| Hachinski, V | 1 |
| Rigsby, CS | 2 |
| Cannady, WE | 1 |
| Dorrance, AM | 3 |
| Otani, L | 1 |
| Yasumatsu, T | 1 |
| Murakami, M | 1 |
| Hayashi, A | 1 |
| Kimoto, K | 1 |
| Murakami, T | 1 |
| Osmond, JM | 1 |
| Smeda, J | 1 |
| Vasdev, S | 1 |
| King, SR | 1 |
| Enea, I | 1 |
| De Paolis, P | 1 |
| Porcellini, A | 1 |
| Piras, O | 1 |
| Savoia, C | 1 |
| Russo, R | 1 |
| Giliberti, R | 1 |
| Gigante, B | 1 |
| Rubattu, S | 1 |
| Conte, G | 1 |
| Ganten, D | 1 |
| Volpe, M | 1 |
| Takeda, Y | 1 |
| Yoneda, T | 1 |
| Demura, M | 1 |
| Furukawa, K | 1 |
| Miyamori, I | 1 |
| Mabuchi, H | 1 |
| Rocha, R | 1 |
| Stier, CT | 1 |
| Osborn, HL | 1 |
| Grekin, R | 1 |
| Webb, RC | 1 |
| Naruse, M | 1 |
| Tanabe, A | 1 |
| Sato, A | 1 |
| Takagi, S | 1 |
| Tsuchiya, K | 1 |
| Imaki, T | 1 |
| Takano, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevalence of Primary Aldosteronism in Patients With Stroke[NCT03789357] | 300 participants (Actual) | Observational | 2018-05-01 | Completed | |||
| Effect of Mineralcorticoid Recept Antagonist on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia：A Multicenter Randomized Controlled Study[NCT05688579] | Phase 4 | 8,000 participants (Anticipated) | Interventional | 2023-04-16 | Enrolling by invitation | ||
| Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study (SomaSignal Study)[NCT04836117] | 200 participants (Anticipated) | Interventional | 2021-08-12 | Recruiting | |||
| Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjec[NCT00134264] | Phase 3 | 15,067 participants (Actual) | Interventional | 2004-07-31 | Terminated | ||
| A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients[NCT04515095] | 30 participants (Actual) | Interventional | 2020-08-16 | Completed | |||
| A Randomized, Double-blind, Placebo-controlled Study Assessing the Effect of RO4607381 on Cardiovascular Mortality and Morbidity in Clinically Stable Patients With a Recent Acute Coronary Syndrome[NCT00658515] | Phase 3 | 15,871 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| Technology Assisted Management of Uncontrolled Hypertension (TEAM-HTN): a Pilot Study[NCT03281772] | 180 participants (Anticipated) | Observational | 2017-01-24 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00658515)
Timeframe: At 53 Months
| Intervention | mg/dL (Least Squares Mean) |
|---|---|
| Dalcetrapib (RO4607381) | 44.96 |
| Placebo | 15.60 |
(NCT00658515)
Timeframe: Throughout Study, up to 53 Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Dalcetrapib (RO4607381) | 226 |
| Placebo | 229 |
Number of cardiovascular events per patient per year (NCT00658515)
Timeframe: From date of randomization to first event up to 48 months
| Intervention | Event per Patient Years of Followup (Number) |
|---|---|
| Dalcetrapib (RO4607381) | 0.034050 |
| Placebo | 0.032759 |
9 reviews available for aldosterone and Apoplexy
| Article | Year |
|---|---|
Aldosterone and cardiovascular diseases.
Topics: Aldosterone; Atherosclerosis; Atrial Fibrillation; Cardiovascular Diseases; Heart Failure; Humans; H | 2023 |
Promise of Physiological Profiling to Prevent Stroke in People of African Ancestry: Prototyping Ghana.
Topics: Aldosterone; Antihypertensive Agents; Ghana; Humans; Hypertension; Multicenter Studies as Topic; Ren | 2022 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P | 2019 |
Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2013 |
Aldosterone as an independent factor in cerebrovascular damage.
Topics: Aldosterone; Animals; Blood Pressure; Cerebrovascular Disorders; Disease Models, Animal; Humans; Hyp | 2008 |
[Non-steroidal anti-inflammatory drugs and risk of stroke in older patients: current controversies and research directions].
Topics: Age Factors; Aged; Aged, 80 and over; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Atherosc | 2011 |
Aldosterone: good guy or bad guy in cerebrovascular disease?
Topics: Aldosterone; Animals; Humans; Mineralocorticoids; Receptors, Mineralocorticoid; Stroke | 2005 |
Is the mineralocorticoid receptor a potential target for stroke prevention?
Topics: Aldosterone; Animals; Cerebrovascular Circulation; Collagen; ErbB Receptors; Humans; Mineralocortico | 2008 |
Pathophysiological effects of aldosterone in cardiovascular tissues.
Topics: Adrenalectomy; Aldosterone; Animals; Cardiovascular Diseases; Cerebral Hemorrhage; Humans; Hypertens | 2001 |
1 trial available for aldosterone and Apoplexy
| Article | Year |
|---|---|
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
33 other studies available for aldosterone and Apoplexy
| Article | Year |
|---|---|
Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Embolic Stroke; Humans; Hyperaldosteronism; Hypertension; Renin; S | 2022 |
Screening for unilateral aldosteronism should be combined with the maximum systolic blood pressure, history of stroke and typical nodules.
Topics: Adrenal Glands; Aldosterone; Blood Pressure; China; Humans; Hyperaldosteronism; Hyperplasia; Middle | 2022 |
The DOCA-Salt Model of Hypertension for Studies of Cerebrovascular Function, Stroke, and Brain Health.
Topics: Acetates; Aldosterone; Brain; Desoxycorticosterone Acetate; Humans; Hypertension; Renin-Angiotensin | 2023 |
Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Middle Aged; Prevalence; Stroke; | 2020 |
Association of -344C/T polymorphism in the aldosterone synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients with hypertension.
Topics: Adult; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Card | 2020 |
Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis.
Topics: Aldosterone; Angiotensin-Converting Enzyme 2; COVID-19; Endothelium, Vascular; Fabry Disease; Female | 2020 |
Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Aorti | 2021 |
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Black or African American; Body Mass Index; Cardiovascu | 2017 |
Renin and aldosterone are not associated with vulnerable plaque characteristics in patients with carotid artery disease.
Topics: Aged; Aldosterone; Biomarkers; Carotid Artery Diseases; Chi-Square Distribution; Endarterectomy, Car | 2018 |
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.
Topics: Aged; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Cholesterol, L | 2018 |
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.
Topics: Aged; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Cholesterol, L | 2018 |
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.
Topics: Aged; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Cholesterol, L | 2018 |
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.
Topics: Aged; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Cholesterol, L | 2018 |
Serum Aldosterone Is Associated with Cerebral Artery Atherosclerosis and Calcification.
Topics: Aged; Aldosterone; Biomarkers; Cerebral Angiography; Cerebral Arteries; China; Computed Tomography A | 2019 |
Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Apoptosis; Blood Pressure; Brain; Hypertension; Lo | 2014 |
Introgressed chromosome 2 quantitative trait loci restores aldosterone regulation and reduces response to salt in the stroke-prone spontaneously hypertensive rat.
Topics: Aldosterone; Animals; Chromosomes; Genotype; Hypertension; Kidney; Male; Quantitative Trait Loci; Ra | 2014 |
RAAS and stress markers in acute ischemic stroke: preliminary findings.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Animals; Biomarkers; Blood Pressure; Female; H | 2015 |
Primary aldosteronism presenting with an atypical aldosterone-renin ratio in the acute phase of cerebral hemorrhage.
Topics: Adult; Aldosterone; Cerebral Hemorrhage; Early Diagnosis; Humans; Hyperaldosteronism; Male; Renin; S | 2015 |
Forced Expiratory Volume in the First Second and Aldosterone as Mediators of Smoking Effect on Stroke in African Americans: The Jackson Heart Study.
Topics: Adult; Aged; Aldosterone; Biomarkers; Black or African American; Blood Pressure; Female; Forced Expi | 2016 |
Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization.
Topics: Aged; Aldosterone; Comorbidity; Female; Hospitalization; Humans; Hyperaldosteronism; Hypertension; J | 2016 |
High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Black People; Blood Pressure; Cytochrome P-450 | 2017 |
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
Topics: Acute Coronary Syndrome; Aged; Aldosterone; Amides; Angina, Unstable; Anticholesteremic Agents; Card | 2017 |
Aldosterone levels and stroke incidence in essential hypertensive patients.
Topics: Aldosterone; Blood Pressure; Cross-Sectional Studies; Female; Follow-Up Studies; Greece; Humans; Hyp | 2010 |
Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Circadian Rhythm; Cross-Sectional Studies; Female; Hear | 2011 |
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
Topics: Age Factors; Aged; Aldosterone; Angioplasty, Balloon, Coronary; Body Mass Index; Brain Ischemia; C-R | 2012 |
Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Blood Pressure; Eplerenone; Hypertension; Male; Medulla Oblongata; Microinject | 2012 |
Aldosterone-to-renin ratio as a predictor of stroke under conditions of high sodium intake: the Ohasama study.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Prospec | 2012 |
Cerebrovascular consequences of pseudohyperaldosteronism.
Topics: Adolescent; Adult; Aged; Aldosterone; Child; Child, Preschool; Cohort Studies; Epithelial Sodium Cha | 2012 |
Association of elevated plasma aldosterone-to-renin ratio with future cardiovascular events in patients with essential hypertension.
Topics: Adult; Aged; Aldosterone; Asian People; Cardiovascular Diseases; Cohort Studies; Essential Hypertens | 2012 |
Serum potassium level and dietary potassium intake as risk factors for stroke.
Topics: Aged; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Potassium, Dietary; Renin; R | 2003 |
Reduction of salt sensitivity in stroke-prone spontaneously hypertensive rats administered an AT1 receptor antagonist during suckling.
Topics: Albuminuria; Aldosterone; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; An | 2006 |
Effect of poststroke captopril treatment on mortality associated with hemorrhagic stroke in stroke-prone rats.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Captopril; | 1999 |
Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Hypertension; Japan; Male; Rats; Rats, Inbred SHR; | 2000 |
Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Cardiovascular System; Diet; Genetic Predisposition to Disease; Hypertension; | 2001 |
Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats.
Topics: Aldosterone; Animals; Aorta; Basal Ganglia; Blood Pressure; Body Weight; Cerebral Cortex; Cerebral I | 2001 |
Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; | 2002 |